The clinical study proves the efficacy and safety of Curalin supplement for blood sugar support.
United States - April 13, 2023 —
Curalife, a leading health and wellness company, announced today the successful results of a clinical trial for its flagship product, Curalin. The double-blind, randomized, placebo-controlled study showed that Curalin significantly helped patients promote healthy blood sugar 2-4 times more effectively than a placebo1. The results were published in Diabetes Metabolism Research and Reviews, a high impact factor medical journal. The trial's principal investigator, Professor Itamar Raz, is considered one of the leading endocrinology researchers in the world, having published over 400 studies in the field.
Curalin is a natural supplement that is designed to help promote healthy blood sugar levels and improve overall health. The supplement, based on traditional Ayurvedic practice, contains a unique blend of 9 natural ingredients that work together to promote healthy blood sugar levels and support a healthy insulin sensitivity.
The clinical trial involved patients who were randomly assigned to receive either Curalin or a placebo for the duration of the study. In addition to significant effectiveness shown in supporting a healthy blood sugar level, the study showed that subjects taking Curalin experienced no adverse events, demonstrating how safe the supplement is. Furthermore, all subjects taking Curalin saw results.
"Curalin's success in this clinical trial is a major milestone for our company and demonstrates the effectiveness of Curalin for promoting healthy blood sugar levels," said Ron Elul, CEO of Curalife. “We are committed to providing safe, effective, and natural products and technologies for people looking to improve their health and achieve lasting health. This study shows that Curalin is a powerful tool for anyone looking to support healthy glucose levels."
A statement by Professor Itamar Raz, the study’s lead investigator and the head of Curalife’s medical advisory board issued a statement saying: "I am pleased with the results of this study, which demonstrate the effectiveness of Curalin in supporting blood sugar levels. As someone who has spent my career researching blood glucose, I believe that Curalin has the potential to make a significant impact on the lives of people around the world."
There are no regulations in the USA requiring clinical studies to be conducted on dietary supplements. But according to CEO Mr. Elul, it was important for Curalife to invest in the study anyways. “Only about 1% of blood sugar support supplements on the market today have studies demonstrating their effectiveness and safety” he notes, “but direct-to-consumer healthcare has become a real option for care for millions of people around the world, and clinical evidence is key to that. We believe patients and customers should expect more from their providers, and we’re living up to that expectation”.
With over 100,000 people using Curalin Curalife is confident that this clinical trial will reinforce Curalin's position as a top natural supplement for individuals seeking to maintain healthy blood sugar levels.
For more information about Curalife, Curalin and its clinical trial, please visit the company's website at www.curalife.com.
Contact Info:
Name: Curalife
Email: Send Email
Organization: Curalife
Address: United States
Website: https://www.curalife.com
Release ID: 89094352
If you detect any issues, problems, or errors in this press release content, kindly contact error@releasecontact.com to notify us. We will respond and rectify the situation in the next 8 hours.
